---
layout: post
title: "Development of a Shared System Risk Evaluation and Mitigation Strategy; Draft Guidance for Industry; Availability; Reopening of Comment Period"
date: 2026-02-05 19:09:02 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-05712
original_published: 2020-03-19 00:00:00 +0000
significance: 8.00
---

# Development of a Shared System Risk Evaluation and Mitigation Strategy; Draft Guidance for Industry; Availability; Reopening of Comment Period

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** March 19, 2020 00:00 UTC
**Document Number:** 2020-05712

## Summary

The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice entitled "Development of a Shared System REMS; Draft Guidance for Industry; Availability" that appeared in the Federal Register of June 1, 2018. The Agency is taking this action to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/03/19/2020-05712/development-of-a-shared-system-risk-evaluation-and-mitigation-strategy-draft-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2020-05712

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
